Plethico Pharmaceuticals plans to raise up to $100 million via the equity route. This was decided at a board meet held by the company on 24 March.
The company can go for either a Qualified Institutional Placement (QIP) or Global Depository Receipts (GDRs) or American Depository Receipts (ADRs) or Foreign Currency Convertible Bonds (FCCBs) or any other security, the company informed stock exchanges.
The company is holding an Extra-ordinary General Meeting on 19 April to seek shareholder approval.
